Showing 8381-8400 of 8875 for: Cochrane Systematic Reviews Back
- Treatment for chronic methicillin‐sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis
Cochrane Systematic Reviews, 27-Jul-2018
Cystic fibrosis is an inherited life-threatening multisystem disorder with lung disease characterized by abnormally thick airway secretions and persistent bacterial infection. Chronic, progressive lung disease is the most important cause of morbidity and
- Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease
Cochrane Systematic Reviews, 14-Mar-2012
Cramps are painful, involuntary muscle contractions. They commonly affect people with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) at all stages of the disease. To date, the treatment of muscle cramps in ALS has been largely empirical with
- Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection
Cochrane Systematic Reviews, 19-Dec-2014
Peripheral neuropathy is the most common neurologic complication of hepatitis C virus (HCV) infection. The pathophysiology of the neuropathy associated with HCV is not definitively known; however, proposed mechanisms include cryoglobulin deposition in the
- Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia
Cochrane Systematic Reviews, 24-Jun-2015
Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by systemic intravascular activation of coagulation, leading to deposition of fibrin in the bloodstream. It may occur in patients with acute and chronic leukemia and is par
- Treatment for dysphagia (swallowing difficulties) in hereditary ataxia
Cochrane Systematic Reviews, 13-Nov-2015
Hereditary ataxias are a heterogeneous group of disorders resulting in progressive inco-ordination. Swallowing impairment, also known as dysphagia, is a common and potentially life threatening sequel of disease progression. The incidence and nature of dys
- Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Cochrane Systematic Reviews, 30-Oct-2014
Accumulating evidence suggests an association between prenatal exposure to antiepileptic drugs (AEDs) and increased risk of both physical anomalies and neurodevelopmental impairment. Neurodevelopmental impairment is characterised by either a specific defi
- Treatment for familial amyotrophic lateral sclerosis/motor neuron disease
Cochrane Systematic Reviews, 21-Jan-2009
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a rare neurodegenerative disease. Approximately 5% to 7% of ALS/MND patients report a family history of a similarly affected relative. Superoxide dismutase-1 gene mutations
- Treatment for femoral pseudoaneurysms
Cochrane Systematic Reviews, 28-Nov-2013
Femoral pseudoaneurysms may complicate up to 8% of vascular interventional procedures. Small pseudoaneurysms can spontaneously clot, but sometimes definitive treatment is needed. Surgery has traditionally been considered the 'gold standard' treatment, alt
- Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders
Cochrane Systematic Reviews, 24-Jan-2007
Fisher syndrome is one of the regional variants of Guillain-Barré syndrome, characterised by impairment of eye movements (ophthalmoplegia), incoordination (ataxia) and loss of tendon reflexes (areflexia). It can occur in more limited forms, and may overla
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis
Cochrane Systematic Reviews, 25-Nov-2021
Several available therapies for neuroendocrine tumours (NETs) have demonstrated efficacy in randomised controlled trials. However, translation of these results into improved care faces several challenges, as a direct comparison of the most pertinent thera
- Treatment for hepatitis C virus‐associated mixed cryoglobulinaemia
Cochrane Systematic Reviews, 7-May-2018
Hepatitis C virus (HCV)-associated mixed cryoglobulinaemia is the manifestation of an inflammation of small and medium-sized vessels produced by a pathogenic IgM with rheumatoid factor activity generated by an expansion of B-cells. The immune complexes fo
- Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis
Cochrane Systematic Reviews, 12-Sep-2019
Hepatorenal syndrome is defined as renal failure in people with cirrhosis in the absence of other causes. In addition to supportive treatment such as albumin to restore fluid balance, the other potential treatments include systemic vasoconstrictor drugs (
- Treatment for HIV‐associated cryptococcal meningitis
Cochrane Systematic Reviews, 25-Jul-2018
Cryptococcal meningitis is a severe fungal infection that occurs primarily in the setting of advanced immunodeficiency and remains a major cause of HIV-related deaths worldwide. The best induction therapy to reduce mortality from HIV-associated cryptococc
- Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis)
Cochrane Systematic Reviews, 8-Jul-2009
Neuralgic amyotrophy (also know as Parsonage-Turner syndrome or brachial plexus neuritis) is a distinct peripheral nervous system disorder characterised by episodes (attacks) of extreme neuropathic pain and rapid multifocal weakness and atrophy in the upp
- Treatment for IgG and IgA paraproteinaemic neuropathy
Cochrane Systematic Reviews, 24-Mar-2015
Paraproteinaemic neuropathy refers to those neuropathies associated with a monoclonal gammopathy or paraprotein. The most common of these present with a chronic, predominantly sensory, symmetrical neuropathy, similar to chronic inflammatory demyelinating
- Treatment for inclusion body myositis
Cochrane Systematic Reviews, 8-Jul-2015
Inclusion body myositis (IBM) is a late-onset inflammatory muscle disease (myopathy) associated with progressive proximal and distal limb muscle atrophy and weakness. Treatment options have attempted to target inflammatory and atrophic features of this co
- Treatment for inhalant dependence and abuse
Cochrane Systematic Reviews, 25-Oct-2010
Inhalants are being abused by large numbers of people throughout the world, particularly socio-economically disadvantaged children and adolescents. The neuropsychological effects of acute and chronic inhalant abuse include motor impairment, alterations in
- Treatment for Lambert‐Eaton myasthenic syndrome
Cochrane Systematic Reviews, 16-Feb-2011
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission. Treatments attempt to overcome the harmful autoimmune process, or improve residual neuromuscular transmission
- Treatment for leiomyosarcoma and leiomyoma in children with HIV infection
Cochrane Systematic Reviews, 14-Apr-2010
Smooth muscle tumour (SMT) composed of leiomyoma and leiomyosarcoma recently has been described in many HIV-infected children. Leiomyosarcoma has become the second most frequent malignancy in children with HIV infection or other immunodeficiency diseases
- Treatment for meralgia paraesthetica
Cochrane Systematic Reviews, 12-Dec-2012
Meralgia paraesthetica is a clinical syndrome for which a number of treatments are in common use, including conservative measures, injection of corticosteroid with local anaesthetic and surgery. We aimed to examine the evidence for the relative efficacy o
